Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed an efficient process to rapidly discover new “enediyne natural products” from soil microbes that could be further developed into extremely potent anticancer drugs.
The study highlights microbial natural products as abundant sources of new drug leads. The researchers’ discovery process involves prioritizing the microbes from the TSRI strain collection and focusing on the ones that are genetically predisposed to produce specific families of natural products. The scientists say this process saves time and resources in comparison to the traditional approaches used to identify these rare molecules.
The study, led by TSRI Professor Ben Shen, was published today in the journal mBio.
Shen and his colleagues uncovered a new family of enediyne natural products, called tiancimycins, (TNMs) which kill selected cancer cells more rapidly and completely in comparison to toxic molecules used in FDA-approved antibody-drug conjugates (ADCs)— monoclonal antibodies attached to cytotoxic drugs that target only cancer cells.
The scientists also discovered several new producers of C-1027, an antitumor antibiotic currently in clinical development, which can produce C-1027 at much higher levels.
It has been more than a decade since Shen first reported on the C-1027 enediyne biosynthetic machinery, and he speculated then that the knowledge obtained from studying biosynthesis of C-1027, and other enediynes, could be used for the discovery of novel enediyne natural products.
“The enediynes represent one of the most fascinating families of natural products for their extraordinary biological activities,” Shen said. “By surveying 3,400 strains from the TSRI collection, we were able to identify 81 strains that harbor genes encoding enediynes. With what we know, we can predict novel structural insights that can be exploited to radically accelerate enediyne-based drug discovery and development.”
“The work described by the Shen group is an excellent example of what can be achieved by coupling state of the art genomic analyses of potential biosynthetic clusters and modern physicochemical techniques,” said David J. Newman, retired chief of the National Cancer Institute’s Natural Products Branch. “As a result of their work, the potential number of enediynes has significantly increased.”
Shen’s method of strain prioritization and genome mining means a far more efficient use of resources involved in the discovery process, targeting only those strains that look to produce the most important natural compounds.
“This study shows that the potential to rapidly discover new enediyne natural products from a large strain collection is within our reach,” said TSRI Research Associate Xiaohui Yan, one of four first authors of the study. “We also show the feasibility of manipulating tiancimycin biosynthesis in vivo, which means that sufficient quantities of these precious natural products can be reliably produced by microbial fermentation for drug development and eventual commercialization.”
Learn more: Scripps Florida Scientists Discover New Natural Source of Potent Anti-Cancer Drugs
[osd_subscribe categories=’anticancer-drug’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “ANTI-CANCER DRUG”‘]
Receive an email update when we add a new ANTI-CANCER DRUG article.
The Latest on: Anticancer drug
[google_news title=”” keyword=”anticancer drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Anticancer drug
- Community invited to ‘Drug Take Back Day’ events to dispose of unused, expired medications in Jacksonvilleon April 27, 2024 at 10:41 am
The Jacksonville Sheriff’s Office, in partnership with Mayo Clinic and UF Health, will participate in two “Prescription Drug Take Back Day” events Saturday.
- Pharmacists warn of drug shortageon April 26, 2024 at 3:55 pm
Hospitals aren't immune from the problem and for them drug shortages can be worrisome. Especially when chemotherapy drugs are among those in short supply. There have been reports of hospitals and ...
- Scientists learn from caterpillars how to create self-assembling capsules for drug deliveryon April 26, 2024 at 8:00 am
Self-assembling molecules that spontaneously organize themselves to form complex structures are common in nature. For example, the tough outer layer of insects, called the cuticle, is rich in proteins ...
- Anticancer Drugs Market Into the Unknown the Evolution of Market Size and Growth Prospectson April 25, 2024 at 9:51 pm
Anticancer Drugs Market is valued approximately at USD 105.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2020-2027. Sales of ...
- A Closed-Loop Drug-Delivery System Could Improve Chemotherapyon April 25, 2024 at 3:19 pm
New CLAUDIA system could continuously monitor patients during an infusion, adjust dosage to maintain optimal drug levels ...
- Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Canceron April 25, 2024 at 2:11 am
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene ...
- Dump unwanted drugs at National Prescription Take Back Day on Saturdayon April 23, 2024 at 12:55 pm
Northeast Ohio hospitals and retail stores are offering safe, designated drug collection sites during National Prescription Take Back Day. The day, sponsored by the Drug Enforcement Administration, ...
- Was President Biden correct in saying Medicare Part D will cap costs at $2,000 for drugs?on April 21, 2024 at 4:03 am
Biden was referring to the Inflation Reduction Act, part of which targeted prescription drug costs. It passed in 2022 with no Republican support.
- National Drug Shortages Hit Record Levelson April 18, 2024 at 12:57 pm
Requesting a refill at the local pharmacy or getting a complete series of a specific chemotherapy is becoming hit-and-miss as problems with the pharmaceutical supply chain mount.
via Bing News